Todd A. Trapp - 03 Nov 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role
Vice President, CFO
Signature
/s/ Marc A. Began (by power of attorney)
Issuer symbol
ABMD
Transactions as of
03 Nov 2021
Transactions value $
-$541,778
Form type
4
Date filed
05 Nov 2021, 16:28
Previous filing
02 Jun 2021
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock, $0.01 par value Award $0 +6.98K +72.38% $0.00 16.6K 03 Nov 2021 Direct F4
transaction ABMD Common Stock, $0.01 par value Tax liability -$542K -1.55K -9.32% $349.76 15.1K 03 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABMD Stock Option (Right to Buy) 7K 03 Nov 2021 Common Stock 0 $266.39 Direct F2, F3
holding ABMD Stock Option (right to buy) 6.53K 03 Nov 2021 Common Stock 0 $223.90 Direct F2, F3
holding ABMD Stock Option (right to buy) 3.74K 03 Nov 2021 Common Stock 0 $283.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4 Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.